Reporting: U.S. BIOSECURE Act

  1. You Want To Rein In China? Then Actually Do It 4/12/2024

    Chief Editor Louis Garguilo takes a hard look at proposed legislation H.R. 7085 - the BIOSECURE Act - and draws out some interesting angles and conclusions regarding the biopharma battle between the U.S. and China.

  2. From Ally To Adversary: BIO's Swift Rebuke Of WuXi 4/5/2024

    The CEO of the Biotechnology Innovation Organization (BIO) spearheading expulsion of WuXi Apptec relied on WuXi Biologics as CEO of the biotech he founded. More on this and some breaking news on the U.S. government's accusations regarding WuXi, from Chief Editor Louis Garguilo.

  3. BIO Expels WuXi, Agrees With U.S. Government 3/14/2024

    “BIO is taking steps now to separate from WuXi-AppTec regarding membership in the organization," says Biotechnology Innovation Organization President & CEO John F. Crowley. But to Chief Editor Louis Garguilo, this seems like a strange company to target.

  4. Is WuXi AppTec An Enemy Of The State? 2/20/2024

    I have zero sympathies for the Chinese communist regime. My stance on tariffs and other economic and market-access blocking measures to combat the regime is more ambivalent. But is WuXi AppTec an enemy combatant against the citizens of the U.S., as proposed legislation assumes?